HopeStage
Back to all studies
CompletedNCT01866098

Naltrexone for Antipsychotic-Associated Weight Gain in Serious Mental Illness

About this titleRead the official source — NCT01866098
Medication studyAges 18–75United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 75 years.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2013
Recruitment status
Completed
Enrollment listed in the registry
144
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT01866098
Official title
Show the full official title

Naltrexone for Antipsychotic-Induced Weight Gain

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Did this study involve medication?

Yes. The study involved medication, including Naltrexone and Placebo.

Who was this study for?

Listed age limits: 18 years to 75 years.

Want to explore more studies?

Explore studies